{"id":"W2119737199","doi":"10.3109/00016340903508650","title":"The market lifecycle of duloxetine for urinary incontinence in Norway","year":2010,"lang":"en","type":"article","venue":"Acta Obstetricia Et Gynecologica Scandinavica","topic":"Pelvic floor disorders treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Norwegian Institute of Public Health; Astellas Pharma; Pfizer; Eli Lilly and Company","keywords":"Duloxetine; Medical prescription; Medicine; Norwegian; Pharmacoepidemiology; Urinary incontinence; Observational study; Prescription drug; Epidemiology; Quarter (Canadian coin); Family medicine; Internal medicine; Alternative medicine; Pharmacology; Surgery","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007956518,0.0001840467,0.0003900215,0.0007961417,0.0003564065,0.0009563353,0.0006139711,0.0003941157,0.002353646],"category_scores_gemma":[0.003661311,0.0003169925,0.0005420945,0.001570755,0.0003474501,0.0007887186,0.0005892189,0.0004764103,0.0002393774],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00140145,"about_ca_system_score_gemma":0.001989515,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1101518,"about_ca_topic_score_gemma":0.1079465,"domain_scores_codex":[0.999002,0.0001378273,0.0001430364,0.0002086165,0.0002948298,0.0002136949],"domain_scores_gemma":[0.9942425,0.0006524139,0.004337259,0.00008604794,0.0002833157,0.0003985747],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001487462,0.00003064342,0.9939128,0.00006351959,0.00003919461,0.0003327754,0.0003720469,0.00009284201,0.0002696002,0.00006561985,0.0005669409,0.004105269],"study_design_scores_gemma":[0.000005195981,0.0000693817,0.9982966,0.00004237038,0.00001267147,0.0002320285,0.0004179065,0.0001354729,0.000043536,0.00001669084,0.0007226795,0.000005371205],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939874,0.001662564,0.00009111733,0.0002866419,0.00002396985,0.00001410429,0.003247917,0.000006028949,0.0006802093],"genre_scores_gemma":[0.9965695,0.00103426,0.0001520036,0.0001039617,0.00002992809,0.00001838994,0.001713261,0.000006862819,0.0003717583],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1101518,"threshold_uncertainty_score":0.2190212,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01137781751398906,"score_gpt":0.2833989325869881,"score_spread":0.272021115072999,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}